Literature DB >> 18223358

Azithromycin in an older woman with diabetic gastroparesis.

Loredana Sutera1, Ligia J Dominguez, Mario Belvedere, Ernesto Putignano, Laura Vernuccio, Anna Ferlisi, Giovanni Fazio, Giuseppe Costanza, Mario Barbagallo.   

Abstract

Diabetic neuropathy is a common chronic complication of diabetes and cause of significant morbidity and mortality, because it may involve the autonomous and peripheral nervous systems. Autonomic diabetic neuropathy is a challenging chronic complication of long-standing diabetes manifested with hypotension, syncope, gastroparesis, diarrhea, constipation, bladder dysfunction, sexual dysfunction, cardiac arrest, and/or sudden death. We present a case of diabetic gastroparesis in an older woman. The patient was an 83-year-old woman with a 40-year history of type 2 diabetes who was admitted with hypoglycemia, malnutrition, persistent vomiting, and obstinate constipation. After several unsuccessful attempts with different therapies, we administered intravenous azithromycin (500 mg/day). After 3 days of treatment, vomiting was resolved and the patient evacuated normal feces, with notable improvement in the general conditions and metabolic control. Because diabetic gastroparesis frequently is difficult to manage clinically and there are few beneficial therapeutic choices available at present, the macrolide antibiotic azithromycin, which has strong prokinetic properties, may be a useful option in the treatment of this complex condition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18223358     DOI: 10.1097/MJT.0b013e31814daff6

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  8 in total

Review 1.  Gastroparesis: pathogenesis, diagnosis and management.

Authors:  William L Hasler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-19       Impact factor: 46.802

Review 2.  Prokinetics in diabetic gastroparesis.

Authors:  Reza A Hejazi; Richard W McCallum; Irene Sarosiek
Journal:  Curr Gastroenterol Rep       Date:  2012-08

3.  Advantages of azithromycin over erythromycin in improving the gastric emptying half-time in adult patients with gastroparesis.

Authors:  Jean M Larson; Anna Tavakkoli; Walter E Drane; Phillip P Toskes; Baharak Moshiree
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

Review 4.  Diabetic gastroparesis: diagnosis and management.

Authors:  Jing Ma; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

5.  Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis.

Authors:  Baharak Moshiree; Renee McDonald; Wei Hou; Phillip P Toskes
Journal:  Dig Dis Sci       Date:  2010-03       Impact factor: 3.199

6.  Pharmacotherapy for gastroparesis: an attempt to evaluate a safer alternative.

Authors:  Uday C Ghoshal
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

7.  Preemptive pyloroplasty for iatrogenic vagus nerve injury in intrahepatic cholangiocarcinoma patients undergoing extensive left-sided lymph node dissection: a retrospective observational study.

Authors:  Shin Hwang; Dong-Hwan Jung; Eun-Kyoung Jwa; Yumi Kim
Journal:  J Yeungnam Med Sci       Date:  2021-12-14

Review 8.  Consequences of COVID-19 for the Pancreas.

Authors:  Urszula Abramczyk; Maciej Nowaczyński; Adam Słomczyński; Piotr Wojnicz; Piotr Zatyka; Aleksandra Kuzan
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.